Objective To investigate the application of percutaneous transhepatic variceal embolization( PTVE) in the treatment of rupture and rebleeding in esophageal and gastric varices after devascularization for liver cirrhosis,and to evaluate its therapeutic effect and advantages. Methods The clinical data of 34 patients with rupture and rebleeding in esophageal and gastric varices after devascularization for liver cirrhosis treated in Department of Gastroenterology,Xiangshui People's Hospital from January 2007 to June 2013 were collected,and all patients received PTVE. Regular gastroscopic reexaminations were performed after the surgery,and postoperative outcome,complications,and the condition of rebleeding were observed. Results Acute-stage hemostasis for 34 patients receiving PTVE was good,with a response rate of 97%( 33 /34); at 2 weeks after surgery,varices disappeared or were significantly relieved in 29 patients( 85. 3%),and after the 2-year follow-up,30 patients( 88. 2%) achieved improvement in or disappearance of esophageal and gastric varices; during the 2-year follow-up,6 patients( 17. 6%) experienced upper gastrointestinal bleeding. No severe complications were observed. Conclusion PTVE has a significant therapeutic effect in the treatment of variceal rebleeding after devascularization for liver cirrhosis,with minimal trauma and few complications,and can prevent the formation of new collateral vessels. Therefore,it is an effective method to treat rupture and rebleeding in esophageal and gastric varices after devascularization for liver cirrhosis.